,36 As such, treatment of C57BL/6 mice with HDAC6 inhibitor reduced disease severity in an SLE preclinical model and akin to our findings with acetate-exposed CIA and T cell dependent vaccination mouse models.13 Here, HDAC6 is linked to systemic lupus erythematosus.